Rezultati pretraživanja
  1. is truly a ✅“TARGET-RICH”👇🏼 disease. 💡For sure everyone➡️genetic testing. Often tissue is ❌. One area where 🧬🩸 can fill that void. – mjesto: UIHC Holden Comprehensive Cancer Center

  2. What is a used for? This simple blood test lets you find out if is developing in your body...before it ever develops into a !

  3. 4. velj
  4. 4. velj

    Nice article adding to prognostic and early predictive power of preop and as minimal residual disease tool post-op in and cancer using CRITICS data. Worth the read.

    Ovo je potencijalno osjetljiv multimedijski sadržaj. Saznajte više
  5. 4. velj
    Odgovor korisnicima i sljedećem broju korisnika:

    All the time! Baseline; but more importantly acquired. One important utility of 👇🏼

  6. 3. velj

    Which genetic tests are best for ? Watch this short video with expert, Alex Rolland, to find out.

  7. 2. velj

    Exciting news for women with who've stopped responding to treatment. New has identified emerging mutations in the gene. Contact us to learn how you can benefit:

  8. Odgovor korisnicima

    Treat the "Pre-stage 4" disease? That's what we want as patients.. CEA seems useless as a marker for about 30% of pts (including me), but I get it every 3 months. A based test would be so useful for us, if it could enable recurrence detection & monitor response to tx.

  9. 1. velj
  10. 1. velj

    Potential clinical applications of circulating glioma extracellular vesicles. 📚The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring

  11. 31. sij

    Does cancer run in your family? ...And do you have any cancer-related inherited mutations?

  12. 31. sij

    Serial plasma collection it's a great opportunity for on

  13. supposed to show up 5-11 months before something shows up on imaging for , how crazy is that??!!

  14. 30. sij

    could be helpful to select patients who may benefit or not from following for stage III by Would be interesting to explore this evidence in negative patients

  15. 30. sij

    Diagnosis of at level increasingly multidisciplinary. When will we see liquid biopsy as routine? Need to profile better to personalise treatment

  16. 30. sij

    Happy and honored to take the challenge of dissecting the role of for in cancer. Looking forward to this terrific

  17. Odgovor korisnicima i sljedećem broju korisnika:

    Can't get this out of my head If like the Stage 3 SU2C trial, CtDNA +ve RC pts randomized to 2L tx or observation arm, is the worry that 2L chemo may not clear CtDNA as well or because the chemo-RT may cause some CtDNA "noise"? Couldn't this be figured out with in hand?

  18. Another CRC pt CtDNA -ve with Signatera ! Test advertised in the 3rd Lane neighborhood of .. It's been on DOWNTOWN for some time, after I collected a whole bunch of info about Signatera from the company Have a test for CRC pts? Tell us

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.